Journal Articles
2020

Unique white matter structural connectivity in early-stage drugnaive Parkinson disease
V. R. Mishra
K. R. Sreenivasan
Z. Yang
X. Zhuang
D. Cordes

See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Medical Molecular Biology Commons

Recommended Citation
Mishra VR, Sreenivasan KR, Yang Z, Zhuang X, Cordes D, Mari Z, Litvan I, Fernandez HH, Eidelberg D,
Walsh RR, . Unique white matter structural connectivity in early-stage drug-naive Parkinson disease. .
2020 Jan 01; 94(8):Article 7154 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/
articles/7154. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu.

Authors
V. R. Mishra, K. R. Sreenivasan, Z. Yang, X. Zhuang, D. Cordes, Z. Mari, I. Litvan, H. H. Fernandez, D.
Eidelberg, R. R. Walsh, and +2 additional authors

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/7154

ARTICLE

Unique white matter structural connectivity in
early-stage drug-naive Parkinson disease
Virendra R. Mishra, PhD, Karthik R. Sreenivasan, MS, Zhengshi Yang, MS, Xiaowei Zhuang, MS,
Dietmar Cordes, PhD, Zoltan Mari, MD, Irene Litvan, MD, Hubert H. Fernandez, MD, David Eidelberg, MD,
Aaron Ritter, MD, Jeffrey L. Cummings, MD, DSc, and Ryan R. Walsh, MD, PhD

®

Neurology 2020;94:e774-e784. doi:10.1212/WNL.0000000000008867

Correspondence
Dr. Mishra
mishrav@ccf.org
or Dr. Walsh
ryan.walsh@
barrowneuro.org

Abstract
Objective
To investigate the topographic arrangement and strength of whole-brain white matter (WM)
structural connectivity in patients with early-stage drug-naive Parkinson disease (PD).
Methods
We employed a model-free data-driven approach for computing whole-brain WM topologic
arrangement and connectivity strength between brain regions by utilizing diﬀusion MRI of 70
participants with early-stage drug-naive PD and 41 healthy controls. Subsequently, we generated a novel group-speciﬁc WM anatomical network by minimizing variance in anatomical
connectivity of each group. Global WM connectivity strength and network measures were
computed on this group-speciﬁc WM anatomical network and were compared between the
groups. We tested correlations of these network measures with clinical measures in PD to assess
their pathophysiologic relevance.
Results
PD-relevant cortical and subcortical regions were identiﬁed in the novel PD-speciﬁc WM
anatomical network. Impaired modular organization accompanied by a correlation of network
measures with multiple clinical variables in early PD were revealed. Furthermore, disease
duration was negatively correlated with global connectivity strength of the PD-speciﬁc WM
anatomical network.
Conclusion
By minimizing variance in anatomical connectivity, this study found the presence of a novel
WM structural connectome in early PD that correlated with clinical symptoms, despite the lack
of a priori analytic assumptions. This included the novel ﬁnding of increased structural connectivity between known PD-relevant brain regions. The current study provides a framework
for further investigation of WM structural changes underlying the clinical and pathologic
heterogeneity of PD.
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Glossary
AD = Alzheimer disease; DaT = dopamine uptake transporter; dMRI = diﬀusion MRI; FA = fractional anisotropy; FW = freewater; HC = healthy controls; Inf-Fron-Tri-Left = left frontal inferior triangularis; MDS-UPDRS-III = Movement Disorder
Society–sponsored Uniﬁed Parkinson’s Disease Rating Scale Part III; MNI = Montreal Neurological Institute; MoCA =
Montreal Cognitive Assessment; NBS = network-based statistic; PALM = permutation analysis of linear models; PD =
Parkinson disease; PPMI = Parkinson’s Progression Markers Initiative; ROI = region of interest; SMA = supplementary motor
area; WM = white matter.

Neuroimaging studies suggest that Parkinson disease (PD) can
be considered a network-disconnection syndrome,1 which may
be studied using network neuroscience approaches. Network
neuroscience has broadly conceptualized the structures and
functions of the brain as large-scale neural networks. It has been
hypothesized that brain network dysfunction results from abnormalities in both anatomical connections and functional
interactions of distributed brain regions.2,3 Recent graphtheoretical ﬁndings4,5 in early PD have suggested that although
the functional modular organization of the PD connectome is
disrupted, the structural organization of the PD connectome
remains relatively preserved albeit with subtle white matter
(WM) connectivity changes.4 It is critical to understand
whether the well-known inherent variability of anatomical
networks6,7 underlies the lack of detected structural disorganization in early PD. Furthermore, it is possible that the wellknown pathologic and symptomatic heterogeneity of PD8
aﬀects the ability to detect consistent disease-relevant structural
changes particularly early in the disease.
Generating a disease-relevant structural connectome, while
minimizing the eﬀect of inherent physiologic variance of anatomical networks and disease heterogeneity, is essential to
improve understanding of structural network pathology in PD
and enhance the reproducibility of structural network ﬁndings. In the current study, we utilized a novel whole-brain
data-driven approach free from a priori assumptions that
permitted focus on those connections that were most consistent across healthy controls (HC) and participants with
early-stage PD to identify a group-speciﬁc WM anatomical
network within both HC and PD. We hypothesized that a PDspeciﬁc WM anatomical network would explain structural
network pathology including decreased structural connectivity between PD-relevant brain regions common across
patients with PD (while enabling the preservation of individual structural anatomical variability) and would correlate
with clinical markers as well as disease progression.

Methods
Participants
All data for this study were derived from the Parkinson’s
Progression Markers Initiative (PPMI) database, which is an
observational multicenter study to identify PD biomarkers.9
Diﬀusion MRI (dMRI) datasets acquired between 2011
and 2015 were downloaded in 2017 through a standard
Neurology.org/N

application process from the PPMI website (ppmi-info.org).
Only the ﬁrst available cardiac-gated dMRI scan with 2 repetitions for each participant was used in this study. Importantly, to minimize the noise characteristics from diﬀerent
scanners, only dMRI scans acquired using 3T Siemens
(Munich, Germany) scanners were utilized in this study.
These criteria yielded dMRI scans for a total of 92 participants
with drug-naive PD and 49 HC that were further used for
preprocessing and quality control.
Standard protocol approvals, registrations,
and patient consents
The PPMI study was approved by the institutional review
board of all participating sites, and written informed consent
was obtained from all participants by the site investigators.
Participant characteristics
As described previously,9 the primary inclusion criteria for all
age-matched HC enrolled in the study were that the participants should be free of any observable neurologic deﬁcits, have
no ﬁrst-degree family members with PD, and score 26 or
greater on the Montreal Cognitive Assessment (MoCA).10 The
inclusion criteria for all participants with PD in the study were
(1) diagnostic criteria for PD met; (2) diagnosed within 2 years
of study enrollment; (3) an abnormal dopamine uptake
transporter (DaT) scan documented; and (4) baseline Hoehn
& Yahr scale score ≤2. A comprehensive baseline clinical
evaluation of behavioral, cognitive, and motor assessments was
performed for every participant by the site investigators. Motor
severity score was calculated for each participant using the
Movement Disorder Society–sponsored Uniﬁed Parkinson’s
Disease Rating Scale Part III (MDS-UPDRS-III).11
Image acquisition
The cardiac gated dMRI datasets used in the current study
were acquired across 12 diﬀerent scanning sites on 3T Siemens scanners with a 12-channel head coil. A 2D echoplanar
diﬀusion sequence with the following measures was used at
each site for every participant: number of diﬀusion encoding
directions = 64, b-value = 1,000 s/mm2, number of nondiﬀusion (b0) images = 1, number of repetitions = 2, matrix
size = 112 × 112, slices = 72, in-plane resolution = 1.98 mm2,
slice thickness = 2 mm, ﬂip angle = 90o, repetition time = 900
ms, and echo time = 88 ms.
In addition, DaT imaging was performed for all participants
using SPECT. Brieﬂy, data were acquired 4 ± 0.5 hours after
Neurology | Volume 94, Number 8 | February 25, 2020
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injection of 5 mCi of DaTscan. The imaging was performed
with a 20% symmetric photopeak window centered on 159
KeV and 122 KeV with the following measures: matrix size =
128 × 128, number of projections = 120 or 90, step size = 3 or
4°. The uptake was calculated in bilateral caudate and putamen and was shared for all participants by the site
investigators.
The details of the scanning measures are available at ppmiinfo.org. Of note, the demographic and clinical variables of the
participants’ data were those recorded closest to the dMRI
scan used in this study.
dMRI preprocessing and quality control
Each participant’s dMRI scans were visually inspected for
signal dropout or other artifacts before any preprocessing.
After visual inspection, the dMRI scans were preprocessed in
FSL using FMRIB software library version 5.0.9 (fmrib.ox.ac.
uk/fsl/). To minimize the inﬂuence of diﬀusion-sensitizing
gradients on dMRI volume, eddy current distortion correction was performed for each scan of every participant using
eddy_correct in FSL. Each participant’s movement in x, y, and
z directions in every volume was computed based on the
output of eddy_correct. Single tensor was then linearly ﬁtted
for every voxel inside the brain using dtiﬁt, and fractional
anisotropy (FA) was estimated in each voxel for every participant. A brain mask with a fractional intensity threshold of
0.2 was computed using bet before tensor-ﬁtting to ensure the
tensors were estimated only inside the brain voxels.
An estimate of total translational motion was calculated using
the output ﬁle of eddy_correct. Brieﬂy, the estimated translation motion in x, y, and z directions between each volume
was summed across all the volumes by taking the root mean
square motion of the 3 directions. Participants with mean
+1*SD of diﬀusion motion greater than a voxel movement in
the slice encoding direction were identiﬁed and removed from
any further analysis. Rotation motion was not included in the
quality control as rotations and translations are highly correlated during scanning.12 This quality control process reduced the dMRI scans to a total of 70 participants with PD
and 41 HC used for further analysis.
The table summarizes the clinical characteristics of all participants included in the current study.
Construction of structural connectome
Whole brain deterministic ﬁber tractography was conducted
with an angle threshold of 35°13 using TrackVis.14 An FA
mask of 0.2 and a length threshold of 10 mm13 was applied to
remove spurious white matter tracts. Resultant whole-brain
connectivity provided the edges for building the structural
connectome. The following steps were utilized to obtain the
nodes in each participant’s native space. First, the Montreal
Neurological Institute (MNI) 152 template was registered to
each participant’s b0 image in native space using linear and
nonlinear registration in FSL. Then, atlases from both
e776
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automated anatomical labeling15 with 90 anatomical regions
of interest (ROIs) (no cerebellar regions) and ATAG16 with
12 anatomical ROIs in the MNI 152 space were transformed
to each participant’s native space with nearest neighbor interpolation. The cortical and subcortical regions in each
participant’s native space thus obtained were treated as nodes.
A weighted structural connectivity matrix was then generated
using the nodes and edges obtained for each participant. Two
nodes (i, j) were said to be structurally connected if there was
a WM ﬁber that had its endpoints in both nodes (i, j). Selfconnectivity of a node was not utilized in this study. Structural
connectivity was weighted by the product of the number of
WM ﬁbers (FN) generated using streamline tractography17
between the 2 nodes, and average FA of these WM ﬁbers to
minimize the inﬂuence of noise in deterministic tractography.
To further minimize the inﬂuence of noise, outlier detection
was performed within each participant’s connectivity matrix
using the interquartile range18 of the connectivity matrix.
Construction of group-specific WM
anatomical network
To extract the most consistent cortical and subcortical connections across participants in each group, a nonparametric
sign-test was conducted with Bonferroni correction (pcorr <
0.05) to identify group-speciﬁc WM anatomical connectivity7
matrices in HC and PD. Importantly, the sign-test not only
minimizes errors resulting from invalid streamline construction due to noise but also minimizes the false positivity inherent in deterministic tractography.7 Both HC and PDspeciﬁc WM anatomical connectivity matrices thus obtained
were used as masks to extract weighted structural connectivity
matrices within each HC and PD participant. Graphtheoretical measures (described below) were then computed using these individual weighted structural connectivity
matrices corresponding to the group-speciﬁc WM anatomical
connectivity, and compared between groups to understand
topologic diﬀerences of the group-speciﬁc WM anatomical
connectivity.
Network topology analysis
Multiple global and local networks can be used to characterize
the topology of a weighted network.3 For the global network
measure analysis, we focused on the small-worldness of groupspeciﬁc WM anatomical connections to determine the eﬃciency of global integration and segregation of information ﬂow
between nodes of the network. Brieﬂy, normalized path length
(λ) can be used as a surrogate of global integration,3 and
normalized clustering coeﬃcient (γ) can be used as a surrogate
of global segregation.3 Small-worldness (σ) in a network exists
if λ ≈ 1 and γ ≫ 1, and suggests optimal information sharing
between the local (γ) and distant neighbors (λ) of a node. We
also computed network modularity,19 which represents the
hierarchy in the network structure.
For local network analysis, we focused on nodal eﬃciency and
degree of the structural connectivity in each group. Brieﬂy,
Neurology.org/N
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Table Participant demographics
Demographics

HC (n = 41)

PD (n = 70)

Sex

HC vs PD
NS (p = 0.64)

Female

14

27

Male

27

43

Handedness

NS (p = 0.46)

Left

4

6

Right

32

60

Mixed

5

4

Age, y

62.12 ± 10.3

61.38 ± 10.11

NS (p = 0.69)

Years of education

15.68 ± 3.11

15.14 ± 2.98

NS (p = 0.4)

Disease duration, mo

NA

11.2 ± 12.69

NA

MDS-UPDRS-III

NA

20.04 ± 8.05

NA

MoCA score

28.17 ± 1.14

27.56 ± 1.88

NS (p = 0.19)

Hoehn & Yahr score (1/2)

NA

29/41

NA

Dominant affected side

NA

Left

NA

26

Right

NA

43

Mixed

NA

1

1.3 ± 0.4

1.32 ± 0.39

Diffusion motion, mm
Site

NS (p = 0.73)
NS (p = 0.4)

1

2

6

2

4

7

3

1

2

4

6

8

5

2

5

6

5

9

7

1

7

8

2

3

9

5

9

10

7

12

11

5

0

1

2

9.51 ± 1.81

5.3 ± 1.43

12
Dopamine transporter scan score

a

p < 0.001

Abbreviations: HC = healthy controls; MDS-UPDRS-III = Movement Disorder Society–sponsored Unified Parkinson’s Disease Rating Scale Part III; MoCA =
Montreal Cognitive Assessment; NA = not applicable; NS = nonsignificant; PD = Parkinson disease.
Values are reported as mean ±SD or n. Results of pairwise statistical comparisons are shown as p values.
a
Dopamine transporter scan scores of caudate and putamen in both hemispheres were summed for each participant.

nodal eﬃciency characterizes the eﬃciency of information
transfer of a node with the rest of the nodes in the network,
both globally (nodal eﬃciency) and locally (nodal local eﬃciency). The nodal degree is the fundamental measure of the
Neurology.org/N

inﬂuence of a node in a network and nodes with a high degree
have a signiﬁcant eﬀect on a network’s information ﬂow.3
Nodal betweenness, in turn, characterizes the role of each
node in information transfer in the network.3
Neurology | Volume 94, Number 8 | February 25, 2020
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The network measures computed in this study were compared between HC and participants with PD to understand
whether there is a change in network topology in the WM
structural connectivity of participants with early PD and to
understand the correlation of these network measures with
clinical measures.

clinical variables. Head motion during dMRI acquisition was
compared using the nonparametric Kruskal-Wallis test. Statistical
signiﬁcance was established at p < 0.05 and the values were
reported as mean ± SD for each demographic and clinical variable.

Computation of participant-level
connectivity score
We calculated overall connectivity strength by computing the
summation of the inner dot product of the group-speciﬁc WM
anatomical connectivity matrix (A) of each participant with

PD,+ ðA × AT Þ, and we used this as a surrogate for a participant’s connectivity score. We further tested whether the connectivity score was correlated with disease duration and severity.

Network-based statistic (NBS)22 was used to perform nonparametric statistical tests to identify whether there was
a diﬀerence in WM structural connectivity between HC and
PD. NBS performs permutation testing using unpaired t tests
with 5,000 permutations. A test statistic was then computed
for each connection, and a threshold of t = 3.122 was applied to
identify a set of suprathreshold connections that showed
signiﬁcant diﬀerences (pcorr < 0.05) in group-speciﬁc WM
anatomical connectivity between the groups.

Rich-club analysis
A rich-club organization is said to be present in a network when
the hubs of a network tend to be more densely connected among
themselves than with nodes with a lower degree. The presence or
absence of a rich-club organization can provide insights into the
higher-order modular structure of a network, thereby providing
information about the network’s resilience, hierarchical ordering,
and specialization.20 An increasing normalized coeﬃcient
Φnorm >1 over a range of nodal degree (k) was said to reﬂect
the existence of a rich-club organization in a network.
Rich-club nodes, feeder nodes, and local nodes were identiﬁed
for each participant using Φnorm for a given k, and the edges
associated with these nodes were categorized into the richclub, feeder, and local edges.20 Feeder and local nodes are
those nodes that either feed to rich-club nodes (feeder) or not
(local). Since every participant within each group can have
diﬀerent nodes that can be identiﬁed as rich-club nodes, an
upper threshold that yields at least one rich-club node in the
group for a maximum k where the rich-club organization was
evident within each group was computed empirically. A further constraint of the same threshold across the groups was
applied to ensure there is no bias on this threshold.
Average rich-club edge strength, feeder edge strength, and
local edge strength were then computed and compared between the groups to understand whether there is a diﬀerence
in the rich-club structural organization in PD, and also
whether edge strengths of the rich-club, feeder, and local
nodes are associated with clinical measures.
All network measures were generated by using in-house
MATLAB codes and GRETNA toolbox.21 Figure 1 depicts
the basic ﬂow of the study.
Statistical analyses

Comparison of group-specific WM structural
connectomes

Comparison of topographic network measures
between HC and PD and correlation of network
measures and clinical measures in PD

Nonparametric statistical analyses of group diﬀerences between global and local network properties, and their correlation with clinical variables, were conducted using the
permutation analysis of linear models (PALM) toolbox in
FSL.23 Signiﬁcance for PALM and NBS was established with
family-wise error correction of pcorr < 0.05. All statistical
comparisons in PALM and NBS were conducted with age,
sex, handedness, years of education, total brain volume, site,
and diﬀusion-motion measures as covariates of no interest.
Data availability
The anonymized data used in this study can be downloaded
from the PPMI website and database.

Results
Demographics and clinical variables
The table summarizes the descriptive statistics for the demographics and clinical scores in participants with PD
and HC.
None of the demographic characteristics, including sex, age,
years of education, or handedness, was signiﬁcantly diﬀerent
(p > 0.05) between the groups. Similarly, there was no signiﬁcant diﬀerence between the groups (p = 0.19) in global
cognition as assessed by MoCA. Patients with PD were early
in the disease: mean disease duration was 11.2 ± 12.69
months, disease severity assessed by MDS-UPDRS-III score
was 20.04 ± 8.05, and 29 and 41 participants with PD were
identiﬁed to have Hoehn & Yahr scale scores of 1 and 2,
respectively. As would be expected, there was a statistically
signiﬁcant diﬀerence (p = 1.96 × 10−17) in the cumulative
DaT scan score between HC and patients with PD.

Demographics and clinical variables

The χ 2 test was used to test the signiﬁcance of categorical demographic variables and the Kruskal-Wallis test was used to determine the statistical signiﬁcance of continuous demographic and
e778
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The mean head motion in HC and patients with PD during
the dMRI scan was 1.3 ± 0.4 and 1.32 ± 0.39 mm, respectively,
and was not found to be signiﬁcantly diﬀerent (p = 0.73).
Neurology.org/N
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Figure 1 Flowchart of the method

The combined automated anatomical labeling (AAL) and ATAG atlases were registered in each participant’s native space to build the structural connectivity
matrix. The edge-weight was computed as product of number of streamlines and average fractional anisotropy of streamlines between the nodes. Outlier
detection was performed using interquartile range, and the weighted connectivity matrices were further utilized for each participant. A group backbone was
computed for both healthy controls (HC) and patients with Parkinson disease (PD) using nonparametric sign test. Using the group backbone as the mask,
network measures were computed for each participant at the backbone of the group.

Group-specific WM anatomical connectivity in
HC and PD
Figure 2 shows a 3D representation of the group-speciﬁc WM
structural connectivity. There were 864 and 1,220 edges
(bilaterally) present in the WM structural connectivity of HC
and participants with PD, respectively. As shown in ﬁgure 2A,
there was 70.54% overlap in the structural connectivity of HC
and participants with PD. There was only 1 connection (between olfactory and frontal orbital gyrus in the right hemisphere) that was found exclusively in HC-speciﬁc WM
structural connectome (ﬁgure 2A), while 179/610 connections (ﬁgure 2A) involving cortical and subcortical regions
such as precentral gyrus, insula, hippocampus, subthalamic
nucleus, substantia nigra, and striatum were exclusively present in the PD-speciﬁc WM structural connectome.
Of note, NBS revealed 9 paths (ﬁgure 2B) involving angular
gyrus, middle temporal gyrus, posterior cingulum, superior
and middle occipital gyrus, caudate, putamen, striatum, supplementary motor area (SMA), precuneus, and frontal gyrus
that were stronger in PD (pcorr < 0.05).
Topologic differences in group-specific WM
connectivity between HC and PD
The global and local structural network properties of the 2
cohorts are depicted in ﬁgure 3. A signiﬁcantly (pcorr < 0.05)
impaired network architecture underlined by global weak
Neurology.org/N

information network transfer (ﬁgure 3A), accompanied by
a signiﬁcant (pcorr < 0.05) increase in nodal degree (ﬁgure 3B)
of left frontal inferior triangularis (Inf-Fron-Tri-Left), was
evident in the PD-speciﬁc WM connectome.
Correlation between global connectivity score
and clinical measures in PD
There was a statistically signiﬁcant (pcorr < 0.05) negative
correlation between disease duration and global WM connectivity score in participants with PD, as shown in ﬁgure 4.
There was, however, no correlation observed between the
global connectivity score of participants with PD and disease
severity or cumulative DaT score.
Correlation between graph-theoretical and
clinical measures
No local or global network measures showed a correlation
with any clinical variables for either group.
Differences in rich-club organization between groupspecific WM connectomes

Both PD and HC-speciﬁc WM networks demonstrated the
presence of a rich-club organization (ﬁgure 5A). A threshold of
80% was determined at the maximal nodal degree (k ≥ 9)
where both HC and PD had at least 1 node that can be classiﬁed as the network hub (rich-club node). This nodal degree
was chosen to maximize the connections between the nodes
Neurology | Volume 94, Number 8 | February 25, 2020
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Figure 2 Group-specific white matter (WM) connectivity and network-based statistical (NBS) results

(A) Group-specific WM connectivity. Top panel shows the group-specific WM structural connectivity computed after Bonferroni correction at pcorr < 0.05. The
paths that were exclusively present in the WM structural connectome of healthy controls (HC) and patients with Parkinson disease (PD), along with the paths
that were present in both HC and patients with PD, are shown. Only 1 path between insula and middle frontal orbital gyrus in the right hemisphere was
exclusively present in the HC-specific WM connectome. Several paths between cortical and subcortical regions such as precentral gyrus, insula, hippocampus,
subthalamic nucleus, substantia nigra, and striatum were exclusively present in the PD-specific WM connectome. (B) NBS results. Paths with structural
connectivity strength greater in patients with PD as compared to HC in group-specific WM structural connectome are shown. NBS paths were considered
significant at pcorr < 0.05. R and L represent right and left hemispheres, respectively.

with the highest nodal degree. Three nodes (left hippocampus
and bilateral insula) in HC and 6 nodes (bilateral insula, bilateral striatum, and bilateral hippocampus) in participants with
PD were identiﬁed to be network hubs that had k ≥ 9 (ﬁgure
5A). Surprisingly, the WM connection strength between the
network hubs (rich-club edges) (ﬁgure 5B) and WM connection strength feeding the network hubs (feeder edge strength
[ﬁgure 5B]) exhibited a signiﬁcantly (pcorr < 0.05) stronger
connection in participants with PD as compared to HC. Although the WM connection strengths that were not connected
to the hubs (local edge strength) did not reach adjusted statistical signiﬁcance (ﬁgure 5B), the same trend was evident as
was seen with rich-club edge strength and feeder edge strength.
Correlation between rich-club measures and
clinical measures
Rich-club strength showed a signiﬁcantly (pcorr < 0.05) positive
correlation with MDS-UPDRS-III. Furthermore, feeder edge
strength showed a signiﬁcantly (pcorr < 0.05) positive correlation with cumulative DaT scan scores in PD (ﬁgure 6). No
correlation was observed between any of the other rich-club
measures and clinical observations in participants with PD.

Discussion
Our data-driven whole-brain proof-of-principle novel analytical
approach, free from a priori assumption, utilizing dMRI from
e780
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early-stage medication-naive PD in the PPMI database, identiﬁed the presence of a distinctive PD-speciﬁc structural connectome, along with the unanticipated novel ﬁnding of
increased structural connectivity between known PD-relevant
brain regions including striatum, caudate, putamen, and SMA.
Some of the identiﬁed brain regions are classically thought to be
involved in default-mode functional connectivity, while striatum, caudate, putamen, and SMA are integrally involved in the
pathophysiology and motoric symptomatology in PD. These
structural connectivity results, when taken together with recent
functional connectivity data,5,24,25 may suggest that structural
connectivity changes constrain functional connectivity in early
PD, resulting in a structurally ﬁxed environment that may alter
functional network capacity, and hence reduce functional network ﬂexibility. Thus, our data support the hypothesis that
structural network changes drive and constrain functional
network capacity observed in early PD.
Despite the short time since diagnosis, mild disease severity,
and disease heterogeneity of the participants with PD in the
present investigation, our study was able to detect robust PDspeciﬁc structural connectivity that was correlated with disease duration, lending pathophysiologic credence to these
data. In addition, the graph-theoretical measures derived using this PD-speciﬁc structural connectome correlated with
disease duration, severity, and DaT deﬁciency, thereby further
bolstering their pathophysiologic relevance, particularly in
Neurology.org/N
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Figure 3 Graph-theoretical measures in the white matter (WM) structural connectivity of Parkinson disease (PD)

(A) Global graph-theoretical measures in the WM structural connectivity ofPD. Significantly lower normalized clustering coefficient, small-worldness, and
modularity was observed in the WM structural connectome for PD, which are plotted as bar plots for both groups. (B) Local graph-theoretical measures in the
WM structural connectivity of PD. Significantly higher nodal degree and nodal efficiency were observed in the left frontal inferior temporal lobe of PD.
Furthermore, higher nodal degree and higher nodal local efficiency were observed in the left frontal inferior triangularis in the WM structural connectome for
participants with PD and are plotted as bar plots for both groups. (A, B) Bar plots show the mean and the SD for each property within each group. HC = healthy
controls.

light of the lack of a priori analytic assumptions. Overall, our
study provides a baseline for future investigations of altered
structural connectivity in PD given the early stage of disease in
the PPMI cohort. Our study also suggests that the distinctive
PD-speciﬁc anatomical connectivity may form the foundation
for developing a diagnostic imaging biomarker to understand
the association of altered structural connectivity with disease
duration, development, and severity in PD.
In addition to involvement of several PD-speciﬁc regions such
as subthalamic nucleus and striatum, it is intriguing that the
connectivity pattern observed in PD-speciﬁc WM anatomical
connectome consisted of various disease-independent regions
such as hippocampus, precentral gyrus, and insula, which have
been implicated in other neurodegenerative disorders such as
Alzheimer disease (AD) and frontotemporal dementia. Incorporating these structural network changes, both at baseline
and longitudinally, with widely reported functional network
changes across various neurodegenerative diseases may provide important interventional targets to mitigate diseasespeciﬁc functional network deﬁciencies.
Contrary to our hypothesis, we found an increase in nodal
strength and local information transfer of Inf-Fron-Tri-Left.
Both Inf-Fron-Tri-Left and angular gyri26 are classically
thought to be involved in semantic language processing, which
is thought to be impaired in PD.27 Also contrary to our hypothesis, both WM connection strength feeding the network
Neurology.org/N

hubs and WM connection strength between the network hubs
demonstrated inverse correlations with clinical variables, suggesting that altered structural conﬁguration in early-stage PD
may be responsible for more rigid functional networks as
revealed through both fMRI24 and electrophysiologic data.28
Alternatively, such increases in local network measures could

Figure 4 Relationship between disease duration and connectivity score derived using white matter (WM)
structural connectome in Parkinson disease (PD)

A significantly (pcorr < 0.05) negative correlation was observed between disease duration and structural connectivity score derived using the WM
structural connectome in PD. Each scatterplot shows a connectivity score for
each participant with PD. The slope was significant (pcorr < 0.05) and was
established with family-wise error correction.
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Figure 5 Rich-club measures

(A) Rich-club in the white matter (WM) structural connectome of healthy controls (HC) and patients with Parkinson disease (PD). Both HC and patients with PD
showed the presence of rich-club from k ≥ 1 to k ≥ 9. The rich-club regimen is shown by the gray rectangle. The average Φnorm is plotted against the degree (k)
for both HC and patients with PD, shown as circles and triangles, respectively. The error bars indicate the deviation across the participants in each group. The
rich-club nodes in both HC and patients with PD were extracted for k ≥ 9 and plotted on Montreal Neurological Institute152 template as red circles. The nodes
identified to be non-rich-club are plotted as gray circles. (B) Differences in the rich-club measures between HC and patients with PD. Significantly higher richclub strength (A) and feeder edge strength (B) were found in PD-specific WM structural connectome as compared to HC. Although differences in local edge
strength did not reach corrected statistical significance, the same trend was evident as was seen for rich-club and feeder edge strength. Significance was
established at pcorr < 0.05 using nonparametric statistical analysis.

represent a compensatory mechanism in early PD where these
regions may selectively be hyperinvolved in information ﬂow
due to disconnection of neighboring nodes communicating
with these selective nodes. Similar compensatory increases
have been hypothesized in AD.29 Further studies are needed,
however, to understand the relationship between local

information transfer and nodal strength with disease progression to further elucidate the role of these brain regions in
the pathophysiology of PD.
Recent studies utilizing graph-theoretical approaches to dMRI
in PD have reported conﬂicting ﬁndings, with some studies

Figure 6 Relationship between rich-club measures and clinical variables

(A) Significantly (pcorr < 0.05) positive relationship was observed between rich-club strength and Movement Disorder Society–sponsored Unified Parkinson’s
Disease Rating Scale Part III (MDS-UPDRS-III). Furthermore, a significantly positive relationship between feeder edge strength and cumulative dopamine
uptake transporter (DaT) score was observed for patients with Parkinson disease (PD), but not for healthy controls (HC). Scatterplot of both rich-club strength
and feeder edge strength are plotted against (A) MDS-UPDRS-III and (B) cumulative DaT score, respectively, for patients with PD and HC. Each scatter
represents the data from each participant. HC and patients with PD are represented as circles and triangles, respectively. Significance was established with
family-wise error correction.
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indicating weak information transfer,30–32 and others not.4,33
These ﬁndings may be aﬀected by the choice of tracking algorithm (probabilistic or deterministic) and by the choice of
edge weights, along with inherent anatomical heterogeneity
among participants. While carefully controlling for anatomical
variability, our ﬁndings were consistent with the reports of
Nigro et al.30 and Wen et al.,33 suggesting that the discrepancies
observed in dMRI-derived graph-theoretical measures may be
guided by a lack of anatomical homogeneity between the participant groups more than the choice of edge weights used to
build the structural connectome. PD-speciﬁc WM anatomical
connectivity was found to depict impaired network architecture
underlined by global weak information network transfer consistent with fMRI graph-theoretical ﬁndings of Tinaz et al.4
However, Tinaz et al.4 found no such diﬀerence using dMRI.
This ﬁnding further suggests that care should be taken to
remove the anatomical heterogeneity bias before performing
graph-theoretical analysis using dMRI in PD.
A potential immediate clinical application of WM connectivity
changes observed in this study involves the ability to compare
changes in participant-speciﬁc anatomical connectivity by
comparing participant-speciﬁc WM anatomical connectivity to
PD-group-speciﬁc WM anatomical connectivity. This should
further enable understanding of patient-speciﬁc structural
changes, which is important to consider in this pathologically
and phenotypically heterogeneous disease. Studies speciﬁcally
powered to investigate this hypothesis are currently underway
using multiple longitudinal PD cohorts, including across disease
severity, symptom subscores, and cognitive impairment severity.
In an eﬀort to avoid inappropriate inference due to potential for
collinearity aﬀecting the results, we restricted this initial proofof-principle analysis to more global clinical measures (e.g.,
UPDRS-III without reference to speciﬁc subscores, disease
duration). Because the PPMI data utilized herein (in our estimation) did not provide the necessary data to address such
questions, we restricted our analyses to all participants with PD
without subcharacterization to avoid overinterpretation and
potential collinearity. Future studies will evaluate whether the
diﬀerences observed in our study could be further diﬀerentiated
among participants with PD with other clinical manifestations
such as atypical parkinsonisms, PD with mild cognitive impairment, and PD with freezing of gait. A limitation in this study
is that there was no statistically signiﬁcant correlation (pcorr <
0.42) observed after removing the participant with disease
duration greater than 80 months (ﬁgure 4), although the
negative correlation between disease duration and connectivity
score was retained. This could be due to a loss in statistical
power or an inherently weak correlation dependent on the
outlier, and hence future studies should conﬁrm this ﬁnding by
including drug-naive patients with PD with disease duration
between 40 and 80 months. In addition, we did not correct for
free-water (FW) contamination34 before ﬁtting the tensors to
obtain FA of the ﬁbers. Future validation studies should estimate the inﬂuence of FW contamination in generating groupspeciﬁc anatomical connectome. Since our study used imaging
Neurology.org/N

sites as a linear cofactor, which may not be ideal,35 future
studies should compare our ﬁndings to data collected at a single
site on drug-naive participants with early-stage PD to evaluate
the eﬀects of scanner noise and other eﬀects that may preclude
observation of certain networks due to variable site-dependent
noise characterization. Furthermore, simultaneous investigation of both functional and structural connectivity
analysis employing this group-speciﬁc WM structural connectivity approach should shed light on the role of anatomical
connectivity in modulating functional connectivity in PD.
By carefully minimizing variance in anatomical connectivity,
this proof-of-concept whole-brain study free from a priori
analytic assumptions on an early-stage PD cohort from
a multisite database identiﬁed a number of PD pathologically
relevant cortical and subcortical regions in the PD-speciﬁc
WM connectome, which demonstrated a novel increase in
structural connectivity when compared to HC, and was associated with impaired modular organization. By identifying
a set of core abnormalities in early PD structural connectivity,
this approach may permit improved ability to understand
structural network–related disease progression and enhanced
detection of changes in this core structural connectivity with
disease-modifying therapies.
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